Results 241 to 250 of about 684,976 (303)

Prognostic value of the modified Model for End-Stage Liver Disease score in patients treated with cardiac resynchronization therapy. [PDF]

Heart Rhythm O2
Long T, Yu Y, Cheng S, Huang H, Hua W.
europepmc   +1 more source

Common Signatures of Altered Gene Regulation and Invasiveness of Different Breast Cancer Cell Lines after Matrix Interface Crossing

Advanced Healthcare Materials, EarlyView.
Interface transmigration reprograms triple‐negative breast cancer cells, triggering a shared switch toward more aggressive and invasive phenotypes. Using a collagen I interface model, this study identifies shared transcriptional changes involving proliferation, chromatin remodeling, and DNA repair pathways.
Cornelia Clemens, Hannah Trampert, Nataliia Kotsiuba, Tilo Pompe   +3 more
wiley   +1 more source

Deciphering the Role of Cancer Stem Cells in Breast Cancer Brain Colonization Using a Novel Patient‐Derived Model

Advanced Healthcare Materials, EarlyView.
This study shows that stem‐like cells isolated from breast cancer brain metastases drive the spread and growth of tumors in the brain. Among them, a highly adhesive subgroup initiates metastasis and resists many drugs. By closely reflecting patient tumors, these models help identify new targets and improve the development of effective treatments ...
Stefania Faletti, Cristina Richichi, Daniela Osti, Elena Ceccacci, Giovanni Bertalot, Camilla Cerutti, Giuseppina Giardina, Adriana Marinaro, Brunella Costanza, Valentina Gambino, Elena Zaccheroni, Daniela Tosoni, Maria G. Filippone, Marcello Del Corvo, Yinxiu Zhan, Teresa Gravina, Davide Corà, Monica Patanè, Bianca Pollo, Maria Giovanna Jodice, Salvatore Pece, Babette B. Weksler, Ignacio A. Romero, Pierre‐Olivier Couraud, Elisabetta Munzone, Massimiliano Del Bene, Francesco DiMeco, Giuliana Pelicci   +27 more
wiley   +1 more source

Circulating Citrate Is Reversibly Elevated in Patients with End-Stage Liver Disease: Association with All-Cause Mortality. [PDF]

Int J Mol Sci
Li Y, Chvatal-Medina M, Trillos-Almanza MC, Bourgonje AR, Connelly MA, Moshage H, Bakker SJL, de Meijer VE, Blokzijl H, Dullaart RPF, TransplantLines Investigators.   +10 more
europepmc   +1 more source

Nanotherapies for Atherosclerosis: Targeting, Catalysis, and Energy Transduction

Advanced Healthcare Materials, EarlyView.
Atherosclerosis management is hindered by poor drug targeting and plaque heterogeneity. Nanotechnology overcomes these barriers via three core strategies: (1) target‐engineered nanocarriers that achieve lesion‐specific precision via ligand modification, biomimetic camouflage, stimuli‐responsive release, and self‐propelling nanomotors; (2) catalytic ...
Yuqi Yang, Jingguo Qu, Tonghuan Xiao, Xinyang Han, Michael Tin‐Cheung Ying   +4 more
wiley   +1 more source

Decoding prognosis in dengue-induced hepatitis: Model for end-stage liver disease <i>vs</i> albumin-bilirubin for predicting liver failure and survival. [PDF]

World J Gastroenterol
Galasso L, Esposto G, Mignini I, Ainora ME, Zocco MA.   +4 more
europepmc   +1 more source

Dobutamine stress echocardiography in end-stage liver disease: Insights from pre-transplant cardiac assessment - A cross-sectional prospective study from a tertiary cardiac centre in South India. [PDF]

Indian Heart J
Neusha D, Agarwala MK, Varma MC, Firdouse S, Demel R.   +4 more
europepmc   +1 more source

Impact of hepatic steatosis on mortality, hepatocellular carcinoma, end-stage liver disease and HBsAg seroclearance in chronic hepatitis B: a United States cohort study. [PDF]

Front Immunol
Yendewa GA, Elangovan A, Olasehinde T, Mulindwa F, Cater MG, Salata RA, Jacobson JM.   +6 more
europepmc   +1 more source

Informal Family Care Partner Well-Being Is Diminished in End-Stage Liver Disease. [PDF]

Nurs Res
Hansen L, Chang MF, Hiatt S, Dieckmann NF, Lee CS.   +4 more
europepmc   +1 more source

Distinct Longitudinal Trajectories of Symptom Burden Predict Clinical Outcomes in End-Stage Liver Disease. [PDF]

Clin Transl Gastroenterol
Hansen L, Chang MF, Hiatt S, Dieckmann NF, Lee CS.   +4 more
europepmc   +1 more source